A huge advertising campaign was launched recently in Thurrock, to highlight the impact a no-deal Brexit could have on daily life in the UK.
10,000 homes in the area received leaflets publicising the impact a no-deal Brexit could have on the NHS, and a huge digital billboard circulating for local passers by to see.
The NHS could be forced to pay more for vital medicine as a result of trade negotiations with the United States after Brexit.
Leaving the EU with no-deal could leave the UK in an even weaker position ahead of the critical negotiations with US President Donald Trump.
The campaign comes as some candidates in the Conservative leadership election continue to talk up the prospect of a no-deal Brexit. The current frontrunner, Boris Johnson, is yet to rule out leaving the NHS “on the table” in trade talks with Donald Trump.
Jackie Doyle-Price, MP for Thurrock, will cast their vote to help decide the winner of the contest and next Prime Minister. The advertising campaign will showcase what a no-deal Brexit could really mean for voters in Thurrock, and invites them to contact Jackie Doyle-Price MP to raise concerns.
Ellie Gellard, Campaigns Director at 38 Degrees, said: “A no-deal Brexit could see our NHS struggling to pay more for vital medicine, our manufacturing industry decimated and British workers losing their jobs. Whether we voted leave or remain, no one voted for this.
“As we speak, MPs including Jackie Doyle-Price are deciding who could be our next Prime Minister. With so much at stake, it is vital that the public’s voices are heard.
“That’s why thousands of people across the country have chipped in to this campaign, to help send a message to MPs and candidates for Prime Minister: do everything in your power to stop a no-deal Brexit.”
The USA has suggested that they’d like to get the NHS to pay more for medicines as part of a trade deal.
The UK government negotiates drug prices with the pharmaceutical industry to control costs.
The US government is aiming to change this arrangement because it puts downward pressure on the revenue of American pharmaceutical companies.
As outlined in the US Trade Representative’s negotiating objectives, the US will aim to use the opportunity of a potential trade deal with the UK in order to increase market access and revenues for American pharmaceutical companies.